AIM
CLMT icon

Acrospire Investment Management’s Calumet Specialty Products CLMT Stock Holding History

Acrospire Investment Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,187
Closed -$48K – 286
2017
Q2 		$48K Buy
+11,187
New +$44.9K 0.05% 893

Other funds holding CLMT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
SPCM
Sound Point Capital Management New York $28.3M AUM 13.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Acrospire Investment Management's CLMT Position: Q3 2017 in Review

Acrospire Investment Management sold out of Calumet Specialty Products (CLMT) in Q3 2017, closing a stake of 11,187 shares — an estimated $48K sold.

Acrospire Investment Management first reported a position in CLMT in Q2 2017 and held it in 1 quarter. The position peaked at $48K in Q2 2017. 72 funds tracked by Wall St. Rank hold CLMT as of Q3 2017.

  • Acrospire Investment Management reported no remaining Calumet Specialty Products position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 11,187 Calumet Specialty Products shares in Q3 2017, an estimated $48K.
  • Acrospire Investment Management first reported a position in Calumet Specialty Products in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's Calumet Specialty Products position peaked at $48K in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.